By Richard Vanderford ( November 15, 2010, 4:41 PM EST) -- Watson Pharmaceuticals Inc. and Abbott Products Inc. have argued in an appellate brief defending their reverse-payment deal that pay-for-delay settlements are not only legal, they make perfect sense given the pressures brand-name drugmakers face under the Hatch-Waxman Act....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.